Clinical Trials Sponsored by Janssen, LP

Total 3092 results

Indiana University School of Medicine
Ortho-McNeil Janssen Scientific Affairs, LLC

Completed

Study of Paliperidone ER in Adolescents and Young Adults With Autism

Autism

United States
Medicine
Janssen Pharmaceuticals; National Medical Research Council (NMRC), Singapore

Unknown

Assessing Progression to Type-2 Diabetes (APT-2D): A Prospective Cohort Study Expanded From BRITE-SPOT (Bio-bank and Registry for StratIfication and Targeted intErventions in the Spectrum Of Type 2 Diabetes) (APT-2D)

Diabetes | Pre-diabetes

Singapore
Paul Steven Yamauchi, MD, PhD
Janssen Services, LLC

Unknown

A Study to Evaluate the Effectiveness of STELARA ™ (USTEKINUMAB) in the Treatment of Scalp Psoriasis

Plaque Psoriasis | Scalp Psoriasis

United States
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Recruiting

An Open-Label Extension and Long-term Efficacy and Safety Monitoring Study of Patients With Crohn's Disease Previously Included in the Loss of RESponse to Ustekinumab Treated by Dose Escalation Study (REScUE-OLE)

Crohn Disease

Belgium
Belgian Inflammatory Bowel Disease Research and...
Janssen Cilag N.V./S.A.

Active, not recruiting

Loss of RESponse to Ustekinumab Treated by Dose Escalation (REScUE)

Crohn Disease

Belgium
Grupo Español de Linfomas y Transplante Autólogo...
Janssen-Cilag, S.A.

Active, not recruiting

Ibrutinib in Combination With Rituximab in Patients With Indolent Clinical Forms of MCL

Mantle Cell Lymphoma

Spain
OHSU Knight Cancer Institute
Janssen Scientific Affairs, LLC; Oregon Health and Science University

Active, not recruiting

Advanced ChemoHormonal Therapy for Treatment Naive Metastatic Prostate Cancer

Metastatic Prostate Carcinoma | Stage IVB Prostate Cancer AJCC v8 | Castration-Sensitive Prostate Carcinoma

United States
Grupo Español de Linfomas y Transplante Autólogo...
Janssen-Cilag, S.A.

Unknown

Ibrutinib in Patients With Refractory/Relapsed Non-GCB Diffuse Large B-cell Lymphoma Non-candidates to Autologous Stem Cell Transplantation

Diffuse Large B-Cell Lymphoma

Spain
Peter J. Ruane, M.D.
Janssen Scientific Affairs, LLC

Completed

Simeprevir in Combination With Sofosbuvir in Treatment-Naïve or -Experienced Adults With Chronic Genotype 4 Hepatitis C Virus Infection

Chronic Hepatitis C

United States
Jonsson Comprehensive Cancer Center
Bristol-Myers Squibb

Completed

Nivolumab and Relatlimab in Treating Participants With Advanced Chordoma

Chordoma | Metastatic Chordoma | Unresectable Chordoma | Locally Advanced Chordoma

United States
Jonsson Comprehensive Cancer Center
Faxitron bioptics, LLC

Completed

SCOUT Reflector for Tagging Lymph Nodes for Targeted Removal in Patients With Breast Cancer

Stage I Breast Cancer AJCC v7 | Stage IA Breast Cancer AJCC v7 | Stage IB Breast Cancer AJCC v7 | Stage II Breast Cancer AJCC v6 and v7 | Stage IIA Breast Cancer AJCC v6 and v7 | Stage IIB Breast Cancer AJCC v6 and v7 | Stage III Breast Cancer AJCC v7 | Stage IIIA Breast Cancer AJCC v7 | Stage IIIB... and other conditions

United States
Jonsson Comprehensive Cancer Center
GlaxoSmithKline; Tesaro, Inc.

Completed

PET Imaging of the Immune System Using Analog Probes

Malignant Melanoma

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in Treating Patients With Metastatic Kidney Cancer

Kidney Cancer

United States
Jonsson Comprehensive Cancer Center
Aventis Pharmaceuticals; Genentec

Completed

Docetaxel and Erlotinib in Treating Older Patients With Prostate Cancer

Prostate Cancer

United States
Jonsson Comprehensive Cancer Center
Pharmacia and Upjohn

Completed

Irinotecan in Treating Patients With Esophageal or Stomach Cancer

Gastric Cancer | Esophageal Cancer

United States
Jonsson Comprehensive Cancer Center
Pfizer; Schering-Plough

Completed

Temozolomide and Sunitinib Malate in Treating Patients With Stage III or Stage IV Malignant Melanoma

Metastatic Melanoma

United States
Nordin Hanssen

Recruiting

Encapsulated Faecal Microbiota Transplantation to Preserve Residual Beta Cell Function in Type 1 Diabetes Mellitus (ENCAPSULATE)

Type 1 Diabetes

Netherlands
Jørgen Bjerggaard Jensen

Active, not recruiting

Neoadjuvant Short-term Intensive Chemoresection Versus Standard Adjuvant Intravesical Instillations in NMIBC (NICSA)

Bladder Cancer

Denmark
Jørgen Bjerggaard Jensen

Withdrawn

Robot-assisted Surgical Resection vs. Cryoablation of Localised Renal Cancer (ROAST)

Renal Cancer

Denmark
Kaj Winther Hansen

Completed

Comparative Study of Turmeric Extract in Patients With Arthrosis.

Quality of Life | Arthralgia | Stiffness of Unspecified Joint, Not Elsewhere Classified | Disturbance of Activity and Attention

Denmark
Annesofie Lunde Jensen

Completed

DiabetesFlex - Patient Involvement and Patient-reported Outcome Measures in Type 1 Diabetes

Type1 Diabetes Mellitus

Denmark
Jørgen Bjerggaard Jensen

Completed

Prospective Versus Retrospective Complications in Radical Cystectomy and Nephrectomy

Renal Cell Carcinoma | Bladder Cancer

Denmark
Toronto Rehabilitation Institute
Rick Hansen Foundation

Completed

FES Therapy:Restoring Voluntary Grasping Function in Chronic SCI

Spinal Cord Injuries

Canada
Jonsson Comprehensive Cancer Center
Progenics Pharmaceuticals, Inc.

Terminated

Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer (PSMA-dRT)

Stage II Prostate Cancer AJCC v8 | Stage IIIA Prostate Cancer AJCC v8 | Stage IIIB Prostate Cancer AJCC v8 | Stage IIC Prostate Cancer AJCC v8 | Stage III Prostate Cancer AJCC v8 | Stage IIIC Prostate Cancer AJCC v8 | Stage IIA Prostate Cancer AJCC v8 | Stage IIB Prostate Cancer AJCC v8 | Stage I Prostate...

United States
Jonsson Comprehensive Cancer Center
POM Wonderful LLC

Completed

Pomegranate Juice in Treating Patients With Recurrent Prostate Cancer

Prostate Cancer

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Adjuvant Bortezomib Maintenance Therapy After Autologous Peripheral Stem Cell Transplantation in Treating Patients With Intermediate or Advanced Multiple Myeloma

Multiple Myeloma and Plasma Cell Neoplasm

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib in Treating Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma

Lymphoma

United States
Jonsson Comprehensive Cancer Center
UroGen Pharma Ltd.

No longer available

Compassionate Use of MitoGel in Upper Tract Urothelial Carcinoma

Urothelial Carcinoma Ureteral Location

United States
Montefiore Medical Center
Icahn School of Medicine at Mount Sinai; Janssen Scientific Affairs, LLC

Recruiting

Social Determinants of Health, Medication Use, and Quality of Life in Inflammatory Bowel Disease

Inflammatory Bowel Diseases

United States
Barbara Ann Karmanos Cancer Institute
Bristol-Myers Squibb; Janssen Pharmaceuticals; Multiple Myeloma Research Consortium

Recruiting

Iberdomide and Daratumumab as Maintenance Therapy After an Autologous Stem Cell Transplant for Multiple Myeloma (IBEX)

Multiple Myeloma

United States
University of Heidelberg Medical Center
Janssen Research & Development, LLC; Deutsche Studiengruppe Multiples Myelom...

Recruiting

GMMG-HD10 / DSMM-XX / 64007957MMY2003, MajesTEC-5 (HD10/DSMMXX)

Multiple Myeloma

Germany
University of California, San Diego
Janssen Biotech, Inc.; The Organization of Teratology Information Specialists

Recruiting

Stelara and Tremfya Pregnancy Exposure Registry OTIS Autoimmune Diseases in Pregnancy Project

Psoriasis | Pregnancy | Crohn Disease | Psoriatic Arthritis

United States
University of Ulm
AbbVie; Roche Pharma AG; Janssen-Cilag Ltd.; German CLL Study Group

Completed

Trial of Ibrutinib Plus Venetoclax Plus Obinutuzumab in Patients With CLL (CLL2-GiVe)

Leukemia, Lymphocytic, Chronic

Germany
Dr. Frank Behrens
Janssen-Cilag Ltd.

Completed

Impact of Concomitant MTX on Efficacy, Safety and Adherence of Ustekinumab-treatment in Patients With Active PsA (MUST)

Psoriatic Arthritis

Germany
The University of Texas Health Science Center at...
Janssen Scientific Affairs, LLC

Completed

Effect of Combined Incretin-Based Therapy Plus Canagliflozin on Glycemic Control and the Compensatory Rise in Hepatic Glucose Production in Type 2 Diabetic Patients

Type 2 Diabetes Mellitus

United States
McNeil AB
Janssen (China) Research & Development Center

Completed

Clinical Study to Assess Bioequivalence Between Nicorette Extra Mint Gum and Nicorette® Mint Gum in Healthy Smokers

Tobacco Dependence

China
University of British Columbia
Eli Lilly and Company; Shire; Purdue University; Janssen-Ortho LLC

Completed

Evaluating Clinical Outcomes of Treatment Effectiveness for Children and Adults With ADHD

Attention-Deficit/Hyperactivity Disorder (ADHD)

Canada
H. Lee Moffitt Cancer Center and Research Institute
National Cancer Institute (NCI); Janssen Pharmaceuticals

Terminated

A Phase II Trial of Early Medical Adrenalectomy for "D0.5" Prostate Cancer

Prostate Cancer

United States
The University of Texas Health Science Center at...
Janssen Pharmaceutica N.V., Belgium

Completed

Do Self-Report and Physician Impressions of Adherence to Oral Antipsychotic Medication Agree With Objective Data?

Schizophrenia | Schizoaffective

United States
Jonsson Comprehensive Cancer Center
Boston Scientific Corporation

Not yet recruiting

Yttrium-90 (Y90) Radioembolization for the Treatment of Early Stage Renal Cell Carcinoma, The RENEGADE Trial

Stage I Renal Cell Cancer | Stage II Renal Cell Cancer

United States
Jonsson Comprehensive Cancer Center
Novartis; Seagen Inc.

Recruiting

Ribociclib, Tucatinib, and Trastuzumab for the Treatment of HER2 Positive Breast Cancer

Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic Stage IIIA Breast Cancer AJCC v8 | Anatomic Stage IIIB Breast Cancer AJCC v8 | Anatomic Stage IIIC Breast Cancer AJCC... and other conditions

United States
Jonsson Comprehensive Cancer Center
Kate Farms Inc

Recruiting

Pea Protein Oral Nutrition Supplement for the Reduction of Gastrostomy Tube Placement Rate in Patients With Locally Advanced Head and Neck Cancer Undergoing Chemoradiation Therapy

Locally Advanced Head and Neck Carcinoma

United States
Jonsson Comprehensive Cancer Center
eHealth International, INC.

Recruiting

A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant

Obesity | Malignant Neoplasm

United States
Jonsson Comprehensive Cancer Center
Stemline Therapeutics, Inc.

Withdrawn

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

Acute Myeloid Leukemia

United States
Jonsson Comprehensive Cancer Center
Arcus Biosciences, Inc.

Suspended

Zimberelimab and Quemliclustat in Combination With Chemotherapy for the Treatment of Patients With Borderline Resectable and Locally Advanced Pancreatic Adenocarcinoma

Borderline Resectable Pancreatic Adenocarcinoma | Locally Advanced Pancreatic Ductal Adenocarcinoma

United States
Jonsson Comprehensive Cancer Center
Prostate Cancer Foundation

Active, not recruiting

Prospective Exploratory Study of FAPi PET/CT in Prostate Cancer With Histopathology Validation (FAPI PET Prost)

Prostate Carcinoma | Recurrent Prostate Carcinoma | Metastatic Malignant Neoplasm in the Prostate Gland

United States
Jonsson Comprehensive Cancer Center
Blue Note Therapeutics

Terminated

Cognitive-Behavioral Stress Management Device for the Treatment of Anxiety and Depressive Symptoms in Patients With Stage I-III Breast or Lung Cancer (BNT001)

Anatomic Stage I Breast Cancer AJCC v8 | Anatomic Stage IA Breast Cancer AJCC v8 | Anatomic Stage IB Breast Cancer AJCC v8 | Anatomic Stage II Breast Cancer AJCC v8 | Anatomic Stage IIA Breast Cancer AJCC v8 | Anatomic Stage IIB Breast Cancer AJCC v8 | Anatomic Stage III Breast Cancer AJCC v8 | Anatomic... and other conditions

United States
Jonsson Comprehensive Cancer Center
Bristol-Myers Squibb

Completed

Nivolumab With or Without Ipilimumab in Treating Patients With Gastrointestinal Stromal Tumor That Is Metastatic or Cannot Be Removed by Surgery

Gastrointestinal Stromal Tumor

United States
Jonsson Comprehensive Cancer Center
Bristol-Myers Squibb

Completed

Paclitaxel and Carboplatin in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy

Prostate Cancer

United States
Jonsson Comprehensive Cancer Center
Millennium Pharmaceuticals, Inc.

Completed

Bortezomib, Temozolomide, and Regional Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme or Gliosarcoma

Brain and Central Nervous System Tumors

United States

Clinical Trials Sponsored by Janssen, LP

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations